Danimer Scientific Inc
NYSE:DNMR
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.25
10.49
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
DNMR Price Targets Summary
Danimer Scientific Inc
According to Wall Street analysts, the average 1-year price target for DNMR is 34.68 USD with a low forecast of 16.16 USD and a high forecast of 42 USD.
DNMR Last Price Targets
Danimer Scientific Inc
The latest public price target was made on Aug 21, 2024 by Charles Neivert from Piper Sandler , who expects DNMR stock to drop by 90% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Charles Neivert
Piper Sandler
|
1
USD
Downside 90% |
2 months ago
Aug 21, 2024
|
Danimer Scientific price target lowered to $1 from $1.25 at Piper Sandler
TheFly
|
Laurence Alexander
Jefferies
|
0.8
USD
Downside 92% |
5 months ago
May 22, 2024
|
Jefferies Downgrades Danimer Scientific (DNMR) to Hold
StreetInsider
|
Charles Neivert
Piper Sandler
|
1.25
USD
Downside 87% |
7 months ago
Apr 8, 2024
|
Piper Sandler Downgrades Danimer Scientific (DNMR) to Neutral, 'Near-Term Uncertainty To Bring Heightened Volatility'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DNMR's stock price target?
Price Target
34.68
USD
According to Wall Street analysts, the average 1-year price target for DNMR is 34.68 USD with a low forecast of 16.16 USD and a high forecast of 42 USD.
What is Danimer Scientific Inc's Revenue forecast?
Projected CAGR
59%
For the last 3 years the compound annual growth rate for Danimer Scientific Inc's revenue is 0%. The projected CAGR for the next 3 years is 59%.